This page is part of the HL7 Europe Medication Prescription and Dispense (v0.1.0-ballot: STU 1 Ballot 1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
Profile: MedicationRequest: MPD
identifier: 100-2/3
status: Active
intent: Option
medication: Melphalan 2 mg oral tablet
subject: Thomas Engine Male, DoB: 1950-09-15 ( 12345)
authoredOn: 2024-10-03
requester: PractitionerRole Clinical oncologist
reasonCode: Multiple myeloma
groupIdentifier: 100
dosageInstruction
timing: Once per 1 day
DoseAndRates
Dose[x] 4 Tablet (Details: SNOMED CT code732936001 = 'Tablet (unit of presentation)')
ValidityPeriod | NumberOfRepeatsAllowed | Quantity |
2024-10-03 --> 2024-12-03 | 1 | 16 Tablet (Details: SNOMED CT code732936001 = 'Tablet (unit of presentation)') |